摘要:
A process is disclosed for the preparation of prostaglandins of the PGF 2α -series, in particular Latanoprost, Bimatoprost and Travoprost, which are active in the treatment of ocular hypertensive conditions and glaucoma. The invention also relates to novel intermediates involved in the synthesis of these prostaglandin-PGF 2α derivatives.